EXHIBIT 10.31 CONFIDENTIAL TECHNOLOGY TRANSFER AGREEMENTTechnology Transfer Agreement • October 24th, 2007 • Focus Media Holding LTD • Services-advertising agencies
Contract Type FiledOctober 24th, 2007 Company Industry
TECHNOLOGY TRANSFER AGREEMENT This Agreement is entered into this 12 day of May, 2000 by and between Evan Gamble ("GAMBLE") and Molecular Robotics, Inc. ("MRI"). WHEREAS GAMBLE has developed certain useful technologies ("Technologies") as are listed...Technology Transfer Agreement • January 22nd, 2001 • Molecular Robotics Inc • Computer peripheral equipment, nec • California
Contract Type FiledJanuary 22nd, 2001 Company Industry Jurisdiction
CORAGE, LTD. TECHNOLOGY TRANSFER AGREEMENTTechnology Transfer Agreement • November 13th, 2002 • DSP Group Inc /De/ • Radio & tv broadcasting & communications equipment • Delaware
Contract Type FiledNovember 13th, 2002 Company Industry JurisdictionThis Technology Transfer Agreement (this “Agreement”), effective as of November 1, 2002 (the “Effective Date”), is entered into by and between DSP Group Ltd. (“DSPGL”), an Israeli corporation, and Corage, Ltd. (“Corage”), an Israeli corporation and a wholly owned subsidiary of DSPGL.
SETTLEMENT AGREEMENT AND MUTUAL GENERAL RELEASETechnology Transfer Agreement • August 4th, 2003 • Ciphergen Biosystems Inc • Laboratory analytical instruments • California
Contract Type FiledAugust 4th, 2003 Company Industry Jurisdictionthis technology transfer agreement (the “Agreement”) is made and entered into on this 7th day of April, 1997 (the “Effective Date”) and is retroactive to September 16, 1996 (the “Retroactive Date”), by and between molecular analytical systems, inc. (“MAS”), a Texas corporation with an address c/o Wagner, Kirkman & Blaine, 1792 Tribute Road, Suite 450, Sacramento, CA 95815, and illumesys pacific, inc. (“IllumeSys”), a California corporation with an address c/o Wagner, Kirkman & Blaine, 1792 Tribute Road, Suite 450, Sacramento, CA 95815.
FIFTH AMENDMENT OF TECHNOLOGY TRANSFER AGREEMENTTechnology Transfer Agreement • July 11th, 2008 • InB:Biotechnologies, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJuly 11th, 2008 Company Industry JurisdictionTHIS FIFTH AMENDMENT OF TECHNOLOGY TRANSFER AGREEMENT is made in Newark, Delaware, on the _17_day of December, 2007, between FRAUNHOFER USA, INC., acting through its Center for Molecular Biotechnology a Rhode Island non-profit corporation, having a place of business at 9 Innovation Way, Suite 200, Newark, Delaware 19711 ("Fraunhofer”); and INB:BIOTECHNOLOGIES INC., having a place of business at 9 Innovation Way, Suite 100, Newark, Delaware 19711 ("INB").
CEVA, INC. TECHNOLOGY TRANSFER AGREEMENTTechnology Transfer Agreement • November 13th, 2002 • DSP Group Inc /De/ • Radio & tv broadcasting & communications equipment • Delaware
Contract Type FiledNovember 13th, 2002 Company Industry JurisdictionThis Technology Transfer Agreement (this “Agreement”), effective as of November 1, 2002 (the “Effective Date”), is entered into by and between DSP Group Inc. (“DSPGI”), a Delaware corporation, and Ceva, Inc. (“Ceva”), a Delaware corporation and a wholly owned subsidiary of DSPGI.
RECITALSTechnology Transfer Agreement • August 29th, 2000 • Villageedocs Inc • California
Contract Type FiledAugust 29th, 2000 Company Jurisdiction
TECHNOLOGY TRANSFER AGREEMENTTechnology Transfer Agreement • June 14th, 2018 • Realm Therapeutics PLC • Pharmaceutical preparations • Pennsylvania
Contract Type FiledJune 14th, 2018 Company Industry JurisdictionThis Technology Transfer Agreement (“Agreement”) is entered into as of April 4, 2018 (“Effective Date”) between Realm Therapeutics, Inc., a Delaware corporation (“RTI”) and Vitold M. Bakhir (“Licensor”) and sets forth the terms and conditions that will apply to the transfer of certain technology and the grant of certain licenses from Licensor to RTI.
EXHIBIT 10.13 RESEARCH COLLABORATION AND TECHNOLOGY TRANSFER AGREEMENTTechnology Transfer Agreement • April 11th, 2000 • Exelixis Inc • Services-commercial physical & biological research • California
Contract Type FiledApril 11th, 2000 Company Industry Jurisdiction
Patent & Technology Transfer AgreementTechnology Transfer Agreement • June 20th, 2021
Contract Type FiledJune 20th, 2021In consideration of my employment and/or continued employment by the Roswell Park Cancer Institute (RPCI) or the Roswell Park Cancer Institute Division of Health Research Inc. (HRI), and/or successor or subsidiary organizations in which RPCIC/HRI may participate as owners, participants or holders of equity interests, I, the undersigned, hereby agree as follows:
TECHNOLOGY TRANSFER AGREEMENTTechnology Transfer Agreement • July 12th, 2005 • Resin Systems Inc • Textile mill products • Alberta
Contract Type FiledJuly 12th, 2005 Company Industry JurisdictionThis Technology Transfer Agreement made and dated January 6, 2003 is between RESIN SYSTEMS INC., an Alberta, Canada corporation (the “Vendor”) and RESIN SYSTEMS INTERNATIONAL LTD., a corporation incorporated under the laws of Barbados (the “Purchaser”).
EX-10.3 4 dex103.htm TECHNOLOGY TRANSFER AGREEMENT BY AND BETWEEN SHIJIAZHUANG PHARMACEUTICAL GROUPTechnology Transfer Agreement • May 5th, 2020 • Hong Kong
Contract Type FiledMay 5th, 2020 JurisdictionPortions of this Exhibit were omitted and filed separately with the Secretary of the Commission pursuant to an application for confidential treatment filed with the Commission pursuant to Rule 24b-2 under the Securities Exchange Act of 1934. Such omissions are designated as ***.
TECHNOLOGY TRANSFER AGREEMENTTechnology Transfer Agreement • January 13th, 2009 • Micron Technology Inc • Semiconductors & related devices • Delaware
Contract Type FiledJanuary 13th, 2009 Company Industry JurisdictionThis TECHNOLOGY TRANSFER AGREEMENT (this “Agreement”), is made and entered into as of this 26th day of November, 2008 (“Effective Date”), by and among Nanya Technology Corporation Nanya Technology Corporation [Translation from Chinese] , a company incorporated under the laws of the Republic of China (“NTC”), Micron Technology, Inc, a Delaware corporation (“Micron”), and Inotera Memories, Inc., a company-limited-by-shares incorporated under the laws of the Republic of China (“Joint Venture Company”). (NTC, Micron and Joint Venture Company are referred to in this Agreement individually as a “Party” and collectively as the “Parties”).
ContractTechnology Transfer Agreement • January 26th, 2011 • Manhattan Scientifics Inc • Miscellaneous electrical machinery, equipment & supplies • New Mexico
Contract Type FiledJanuary 26th, 2011 Company Industry JurisdictionThe confidential portions of this exhibit have been filed separately with the Securities and Exchange Commission pursuant to a confidential treatment request in accordance with Rule 406 under the Securities Act of 1933, and Rule 24b-2, under the Securities Exchange Act of 1934, Redacted portions of this exhibit are marked by an ***.
TECHNOLOGY TRANSFER AGREEMENTTechnology Transfer Agreement • February 15th, 2005 • Infitech Ventures Inc • Petroleum refining
Contract Type FiledFebruary 15th, 2005 Company Industry
RECITALSTechnology Transfer Agreement • March 28th, 2003 • Parthusceva Inc • Semiconductors & related devices • Delaware
Contract Type FiledMarch 28th, 2003 Company Industry Jurisdiction
EXECUTION VERSION TECHNOLOGY TRANSFER AGREEMENTTechnology Transfer Agreement • May 5th, 2020 • New York
Contract Type FiledMay 5th, 2020 JurisdictionThis Technology Transfer Agreement (this “Agreement”) is effective as of June 28, 2018 (the “Effective Date”), by and between Masthercell Global Inc., a Delaware corporation (“MTH Global”), and Orgenesis Inc., a Nevada corporation (including its Affiliates, “Orgenesis”). MTH Global and Orgenesis are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
Technology Transfer Agreement between Merck KGaA (“Merck”), Frankfurter Strasse 250, 64271 Darmstadt and Nitec Pharma AG (“Nitec Pharma”) Switzerland PreambleTechnology Transfer Agreement • October 21st, 2010 • Horizon Pharma, Inc. • Pharmaceutical preparations
Contract Type FiledOctober 21st, 2010 Company IndustryMerck has been marketing corticoids (Fortecortin, Decortin, Decortin H, Solu Decortin H) successfully – primarily in Germany – for many years. In order to support the corticoid business Merck started developing Prednison Night Time Release in 1998, which is a novel galenic formulation using the active agent prednison. For the treatment of rheumatoid arthritis (“RA”) the Project (as defined hereinafter) has not yet entered phase 3 of clinical testing.
Technology Transfer Agreement By and Among Maxygen, Inc. Maxygen Holdings Ltd. Maxygen ApS and Bayer HealthCare LLC Dated July 1, 2008Technology Transfer Agreement • January 9th, 2009 • Maxygen Inc • Services-commercial physical & biological research • New York
Contract Type FiledJanuary 9th, 2009 Company Industry JurisdictionThis Technology Transfer Agreement (this “Agreement”) is made and entered into on this 1st day of July 2008 (the “Execution Date”), by and between Maxygen, Inc. (“Maxygen”), a Delaware corporation, Maxygen Holdings Ltd. (“Holdings”), a wholly owned subsidiary of Maxygen and a company organized under the laws of the Cayman Islands, Maxygen ApS, a wholly owned subsidiary of Holdings and a company organized under the laws of the Kingdom of Denmark (“ApS”), and Bayer HealthCare LLC (“Bayer”), a Delaware limited liability company.
EX-10.24 23 d316941dex1024.htm TECHNOLOGY TRANSFER AGREEMENT TECHNOLOGY TRANSFER AGREEMENT THIS TECHNOLOGY TRANSFER AGREEMENT (THIS “Agreement”) IS ENTERED INTO AS OF THIS 29TH DAY OF FEBRUARY, 2012, BY AND BETWEEN: The Proprietor and the Recipient...Technology Transfer Agreement • May 5th, 2020 • California
Contract Type FiledMay 5th, 2020 JurisdictionWHEREAS, the Proprietor has developed LCDTV 8CH + Boost LED BLU Driver and LCDTV TCON Bias PMIC products, the details of which are set forth on Schedule 1 attached hereto (the “Target Products”) and is the proprietor of certain know-how and confidential information relating to their designs, applications and/or manufacture;
TECHNOLOGY TRANSFER AGREEMENT Dated December 18, 2012 By and Between DOMAIN RUSSIA INVESTMENTS LIMITED And REGADO BIOSCIENCES, INC.Technology Transfer Agreement • April 29th, 2013 • Regado Biosciences Inc • Pharmaceutical preparations • New York
Contract Type FiledApril 29th, 2013 Company Industry JurisdictionTHIS TECHNOLOGY TRANSFER AGREEMENT (the “Agreement”) is dated as of December 18, 2012 (the “Effective Date”), by and between Domain Russia Investments Limited, a private limited company incorporated and existing under the laws of England and Wales with registration number 7899075, having its registered office at c/o Maples Corporate Services Limited, PO Box 309, Ugland House, Grand Cayman, KYI-1104, Cayman Islands (“DRI” or “Transferee”), and Regado Biosciences, Inc., a corporation organized under the laws of the State of Delaware, USA, and having its place of business at 318 Blackwell Street, Suite 130 Durham, North Carolina, 27701 USA (“Company”). DRI and the Company may each be referred to herein as a “Party” or, collectively, as “Parties.”
EX-10.6 10 a2220119zex-10_6.htm EX-10.6 THIS DOCUMENT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST PURSUANT TO RULE 406 UNDER THE SECURITIES ACT OF 1933, AS AMENDED. REDACTED MATERIAL IS MARKED WITH [XXXXXXXXX] AND HAS BEEN...Technology Transfer Agreement • May 5th, 2020 • New York
Contract Type FiledMay 5th, 2020 JurisdictionTHIS TECHNOLOGY TRANSFER AGREEMENT (the “Agreement”) is dated as of 4 December 2012 (the “Effective Date”), by and between Domain Russia Investments Limited, a private limited company incorporated and existing under the laws of England and Wales with registration number 7899075, having its registered office at The Broadgate Tower, Third Floor, 20 Primrose Street, City of London, EC2A 2RS, United Kingdom (“DRI”), and Marinus Pharmaceuticals, Inc., a corporation organized under the laws of the State of Delaware, USA, and having its place of business at 21 Business Park Drive, Branford, Connecticut 06405, USA (“Company”). DRI and Company may each be referred to herein as a “Party” or, collectively, as “Parties.”
TECHNOLOGY TRANSFER AGREEMENTTechnology Transfer Agreement • December 2nd, 2017
Contract Type FiledDecember 2nd, 2017[2] (hereinafter referred to as the "Transferor"), a company duly incorporated and existing under the laws of [3] and [4] (hereinafter referred to as "Transferee"), a company duly incorporated and existing under the laws of [5].
RECITALSTechnology Transfer Agreement • March 3rd, 1999 • Aps Holding Corporation • Wholesale-motor vehicle supplies & new parts • Delaware
Contract Type FiledMarch 3rd, 1999 Company Industry Jurisdiction
TECHNOLOGY TRANSFER AGREEMENT Between ..........management LIMITED And .......... Vietnam co., ltd PREAMBLETechnology Transfer Agreement • August 21st, 2015
Contract Type FiledAugust 21st, 2015This Technology Transfer Agreement (hereinafter referred to as the “Agreement”) is entered into on this [] day of [ ]2005 by and between:
CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE SUCH INFORMATION BOTH IS NOT MATERIAL AND WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED ** Technology Transfer AgreementTechnology Transfer Agreement • October 9th, 2020 • Qualigen Therapeutics, Inc. • Pharmaceutical preparations • Hong Kong
Contract Type FiledOctober 9th, 2020 Company Industry JurisdictionThis Technology Transfer Agreement between Qualigen, Inc. (“Qualigen”), a legal entity incorporated in Delaware, USA, with its offices at 2042 Corte del Nogal, Suite B, Carlsbad, California 92011, USA; and Yi Xin Zhen Duan Jishu (Suzhou) Ltd. (翊新诊断技术(苏州)有限公司) (“Licensee”), a legal entity registered in Room 301, 302, Building 9, No. 188 Fu Chung Jiang Lu, Suzhou High Technology Zone, Suzhou,(中国苏州富春江路188号9号楼301,302室), the People’s Republic of China (individually “Party” and together “Parties”), is effective as of October 7, 2020 (“Effective Date”).
EXHIBIT 10.12 CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. THE LOCATIONS OF THE OMITTED MATERIALS ARE INDICATED BY THE FOLLOWING NOTATION: [***] TECHNOLOGY TRANSFER AGREEMENT THIS TECHNOLOGY TRANSFER...Technology Transfer Agreement • March 7th, 2008 • Allegro Microsystems Inc • Semiconductors & related devices • Massachusetts
Contract Type FiledMarch 7th, 2008 Company Industry Jurisdiction
Technology transfer agreementTechnology Transfer Agreement • January 14th, 2021
Contract Type FiledJanuary 14th, 2021
BETWEENTechnology Transfer Agreement • March 15th, 2018
Contract Type FiledMarch 15th, 2018
ContractTechnology Transfer Agreement • April 27th, 2017
Contract Type FiledApril 27th, 2017Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
TECHNOLOGY TRANSFER AGREEMENTTechnology Transfer Agreement • November 16th, 2020
Contract Type FiledNovember 16th, 2020day of in the Christian Year Two Thousand _____ BETWEEN ABC Private Ltd., a Private Limited Company incorporated under the provisions of the Companies Act, 1956/2013, having its registered office at
THE AGETechnology Transfer Agreement • January 13th, 2005 • Shanda Interactive Entertainment LTD • Services-business services, nec
Contract Type FiledJanuary 13th, 2005 Company Industry
TECHNOLOGY TRANSFER AGREEMENTTechnology Transfer Agreement • February 11th, 2019 • Petroteq Energy Inc. • Drilling oil & gas wells
Contract Type FiledFebruary 11th, 2019 Company IndustryBETWEEN: MCW Energy Group Limited (the “Company”), a corporation organized and existing under the laws of the New Brunswick of Canada.
Technology Transfer Agreement SignedTechnology Transfer Agreement • March 27th, 2017
Contract Type FiledMarch 27th, 2017Below : Shri A P Vora, Head-GLMD/OPMG/MESA and Shri Arup Banerjee- Head-SFSD/EOSG/SEDA handing over the Technology Transfer Document to Shri Sandeep Shah-Managing Director, M/s. OSPL, Ahmedabad, in presence of Shri Tapan Misra-Director, SAC
TECHNOLOGY TRANSFER AGREEMENTTechnology Transfer Agreement • July 22nd, 2004 • Cabg Medical Inc • Minnesota
Contract Type FiledJuly 22nd, 2004 Company JurisdictionThis Agreement is made as of 5 JUNE, 1996 by and between Manuel A. Villafaña, a Minnesota resident (“Transferee”) and ATS Medical, Inc., a Minnesota corporation (“ATS”).